Movement Alert｜GENSCRIPT B-1K Intraday Rise 3.66% in Regular Trading, institutional accumulation and CARVYKTI sales support sentiment

Market Focus10-27 09:31

On October 27, GENSCRIPT B-1K rose 3.66% in Regular Trading, trading at HK$32.52, with turnover of HK$64.16 million.

The move coincided with continued market focus on recent institutional accumulation and solid commercial progress of CARVYKTI. Recent disclosures showed FIL Limited increased its stake by about 10.47 million shares on October 16 at an average price of about HK$33.54 per share, involving roughly HK$351 million, lifting its holding ratio to 9.26%. Earlier, FMR LLC increased its position by about 4.74 million shares on October 15 at about HK$32.78 per share.

On product fundamentals, the company disclosed that CARVYKTI generated trade sales of about US$710 million in the quarter ended September 30. Combined with first-half revenue of US$1.254 billion, sales for the first three quarters reached about US$1.964 billion, up 47.4% year on year, reinforcing sentiment around the company’s cell therapy exposure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment